21. Kheirandish-Gozal L, Goza lD. Obstructive Sleep Apnea and Inflammation: Proof of Concept Based on Two Illustrative Cytokines. International Journal of Molecular Sciences. 2019; 20(3): 459.
22. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 2005; 112(17): 2660 - 2667.
23. Чучалин АГ. Хроническая обструктивная болезнь легких. М.: Издательский дом «Атмосфера»; 2018. 56 c. [Chuchalin AG. Chronic obstructive pulmonary disease. M.: Publishing house “Atmosphere”; 2018. 56 p. (In Russian)]
24. Murphy AM, Thomas A, Crinion SJ, Brian D, Kent BD, Tambuwala MM, Fabre A, Pepin J-L, Roche HM, Arnaud C, Ryan S. Intermittenthypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation. European Respiratory Journal. 2017;
25. Bruemmer DC. Peptide in Insulin Resistance and Vascular Complications: Teaching an Old Dog New Tricks. Circulation Research. 2006;
26. Khana HA, Sobkib SH, Ekhzaimyc A, Khand I, Almusawie MA. Biomarker potential of C-peptide for screening of insulin resistance in diabetic and non-diabetic individuals. Saudi Journal of Biological Sciences. 2018